
Pictet Private Equity Investors S.A.
Description
Pictet Private Equity Investors S.A. operates as a key component of Pictet Alternative Advisors (PAA), the dedicated unit for alternative investments within the broader Pictet Group. Founded in Geneva in 1805, Pictet is one of Switzerland's largest independent wealth and asset managers, overseeing substantial assets. As of December 31, 2023, the Pictet Group managed an impressive CHF 633 billion (approximately $740 billion USD) in assets under management and custody, underscoring its significant financial scale and long-standing presence in the global financial markets.
PAA's private equity strategy is comprehensive and diversified, encompassing primary fund commitments, secondary transactions, and direct co-investments. They partner with leading private equity managers worldwide, investing across a wide spectrum of strategies including buyouts, growth equity, venture capital, and distressed situations. This multi-faceted approach allows them to access a broad range of private market opportunities and manage risk effectively.
While a significant portion of their activity involves committing substantial capital to private equity funds – for instance, their Pictet Private Equity Investors VIII fund closed at $2.3 billion – PAA also actively engages in direct co-investments alongside their established fund managers. These co-investments represent their direct equity participation in portfolio companies, providing an additional avenue for value creation. For such direct co-investments, typical first check sizes can range from approximately $10 million to $50 million, depending on the specific deal size and opportunity.
Investor Profile
Pictet Private Equity Investors S.A. has backed more than 26 startups, with 3 new investments in the last 12 months alone. The firm has led 1 rounds, about 4% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series D, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, France.
- Strong thematic focus on Biotechnology, Software, Pharmaceutical.
- Typical check size: $10M – $50M.
Stage Focus
- Series B (31%)
- Series D (12%)
- Series Unknown (12%)
- Series E (12%)
- Series A (12%)
- Series F (8%)
- Series G (4%)
- Post Ipo Debt (4%)
- Private Equity (4%)
- Seed (4%)
Country Focus
- United States (50%)
- Switzerland (23%)
- France (12%)
- India (4%)
- Czech Republic (4%)
- United Kingdom (4%)
- Hong Kong (4%)
Industry Focus
- Biotechnology
- Software
- Pharmaceutical
- Medical
- Fintech
- Artificial Intelligence (Ai)
- Health Care
- Financial Services
- Finance
- Saas
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.